Cart

Sampling fee?

The sample collection fee is a fixed cost that refers to the visit to the clinic where you submit your sample. The fee is not affected by how many tests you have ordered, but varies depending on the order value:

  • For order values under SEK 350, the sampling fee is SEK 129.
  • For order values between SEK 350 and SEK 1000, the fee is SEK 59.
Free sampling fee

For purchases over 1000 SEK, the sampling fee is included.

Get 10% off your first order with code TESTM10
SSB

S-Anti-SSB

S-Anti-SSB (also called anti-La) is an autoantibody that is often found in autoimmune diseases such as Sjögren's syndrome and SLE. It is analyzed with a blood test and is used to confirm the diagnosis, especially in combination with anti-SSA.

What is S-Anti-SSB?

S-Anti-SSB, also called anti-La, is an autoantibody, it is specifically directed against a nuclear protein in the body's cells. S-Anti-SSB often occurs together with anti-SSA (anti-Ro) and is mainly used in the investigation of Sjögren's syndrome and SLE (systemic lupus erythematosus). The antibodies can be detected via a blood test and are an important part of the serological assessment in suspected autoimmune disease.

Why is S-Anti-SSB analyzed?

S-Anti-SSB is primarily analyzed to:

  • Confirm the diagnosis of Sjögren's syndrome, especially in combination with anti-SSA
  • Strengthen the suspicion of SLE in serological investigations
  • Differentiate between different autoimmune conditions
  • Provide guidance when investigating diffuse symptoms such as fatigue, dry eyes or joint pain

How do you interpret a positive S-Anti-SSB?

A positive S-Anti-SSB blood test means that the immune system has have formed antibodies against the La antigen. These antibodies are common in Sjögren's syndrome, especially when they occur together with anti-SSA. However, they can also be detected in people without symptoms or in connection with other autoimmune conditions.

In pregnancy, the presence of anti-SSB is less risky than the presence of anti-SSA, but the presence of both antibodies in the mother can increase the risk of neonatal lupus in the child. Therefore, special monitoring may be necessary if antibodies are detected during pregnancy.